Because knowing is the earliest intervention
We know that when there is early concern, every moment counts.
But too many children are diagnosed long after they have outgrown the critical early neurodevelopmental window when interventions have the greatest life-changing impact.
Our breakthrough diagnostic technology allows you to more definitively understand your kids’ developmental picture, so you can take earlier action to better support them.
For prescription use only
Introducing Canvas Dx, the first and only FDA authorized diagnostic that equips more clinicians to rapidly and accurately diagnose or rule out autism in children ages 1.5 to 6 years, better plan for next steps, and unlock services.
Canvas Dx is now reimbursed by Highmark commercial plans
Get up and running with Canvas Dx in your practice today!
I want to use Canvas Dx at my patients’ next well check visits, before autism goes unnoticed:
Canvas Dx is simple to use
The caregiver uses a simple app to answer questions and record and upload two home videos – all from the comfort of their own home.
The clinician completes a questionnaire about the child’s development and behavior in a web portal.
Canvas Dx does the rest. Our AI combines all this data to generate a highly accurate prediction of autism and additional information of the child’s developmental and behavioral strengths and concerns.
The clinician can immediately review the Canvas Dx result and child development report in the web portal. Diagnostic report-building features saves time to complete required documentation to support access to services and reimbursement.
See how Canvas Dx works
See how Canvas Dx works
Canvas Dx has revolutionized my approach to conducting autism diagnostic assessments with children aged 18 months to 6 years. It has reduced my assessment and report-writing time per patient by 50-70%, resulting in me being able to see patients within 2-4 weeks of a requested assessment. Canvas gives me added confidence in the diagnostic conclusions that I make, because it captures and objectively analyzes data from multiple sources: short video clips of the child, a brief parent-questionnaire and a brief healthcare provider questionnaire.
Now we finally have the opportunity to streamline the diagnostic journey, freeing up specialists to focus on children with complex presentations, so that families with developmental concern for their children can receive the care they need sooner.
Digital diagnostics and therapeutics hold immense potential to bridge the gaps in developmental and behavioral pediatrics, enabling equitable healthcare for all children, regardless of geographical location or limitations in local healthcare resources. By harnessing the power of technology, Cognoa provides the tools to overcome barriers, expand access, and deliver personalized care, ultimately ensuring that every child receives the support they need to thrive.
The wait lists are so long that my patients can’t even get on the waitlist to be seen! With Canvas Dx, I evaluated siblings and got answers immediately. I was able to make an autism diagnosis and begin therapies right away for an 18-month old and I could rule out autism in the older sibling and begin the correct services they needed without the wait. Canvas Dx is a wonderful resource that we have needed for a long time.
Know more sooner, so you can act earlier.
Now, your first action when there is early developmental concern can be diagnosis. Canvas Dx is the crucial first step to understand and meet your patients’ needs, so kids can flourish and live their most fulfilling lives.
2. Kraft. et al. An Aggregate and Deidentified Analysis of Real-World Performance of an Artificial Intelligence- based Diagnosis Aid for Autism Spectrum Disorder. Presented at PAS (Poster presentation) (2023).
3. Maenner, M. J. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018. MMWR Surveill. Summ. 70, (2021).
